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Abstract A cDNA clone (C1) coding for human preprocathep- 
sin C was isolated from a human ileum cDNA library using a rat 
kidney-derived RT-PCR probe and its complete nucleotide se- 
quence determined. The full-length 1857 bp sequence codes for 
a protein of 463 amino acid residues with a calculated molecular 
mass of 51848 Da. Comparison of the deduced amino acid se- 
quence with that of rat preprocathepsin C indicates an 87.5% 
identity. A multiple alignment of the deduced cathepsin C se- 
quence of 233 residues which, by analogy to other cysteine pro- 
teinases, corresponds to the mature protein, confirms that human 
cathepsin C belongs to the papain superfamily. 
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1. Introduction 
Cysteine proteinases are remarkably widespread and are 
present in almost all life forms. They catalyze the hydrolysis of 
many proteins with different specificities and are considered to 
play an important role in intracellular protein degradation and 
turnover [1]. The primary structures of human cathepsins B, L, 
H, S, K and O have been reported as protein sequences data 
or as deduced from their cDNAs. Since their sequences share 
a high degree of similarity and are similar to that of papain, they 
all belong to the papain superfamily [2]. 
Cathepsin C or dipeptidyl aminopeptidase I (EC 3.4.14.1) is 
a lysosomal proteinase, capable of removing dipeptides sequen- 
tially from the amino terminus of peptide and protein sub- 
strates [3]. It has been reported that for the dipeptidyl amin- 
opeptidase activity, cathepsin C requires halide ion as well as 
reducing agents to achieve maximal hydrolytic activity [4]. 
Cathepsin C is, in addition to lysosomal proteolysis, involved 
in the functions of the alimentary tract [5], cell growth [6], 
neuraminidase activation [7] and proliferation of basal cell car- 
cinomas [8]. Thiele and Lipsky reported that cathepsin C activ- 
ity is present at higher levels in cytotoxic lymphocytes and 
myeloid cells, indicating its involvement in the induction, devel- 
opment or differentiation of cytolytic effector cells [9]. 
Unlike cathepsins B, H, L and S, which are small monomeric 
proteins with molecular masses of 20-30 kDa, cathepsin C is 
a high molecular mass oligomeric protein of about 200 kDa, as 
estimated from gel filtration analysis [10,11]. Recently, a cDNA 
clone coding for rat cathepsin C was isolated from a rat kidney 
cDNA library [5]. The deduced amino acid sequence has shown 
that rat cathepsin C has an extremely long propeptide and 
apparently belongs to the papain superfamily. 
In this paper, we present for the first time the entire amino 
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acid sequence of the human preprocathepsin C deduced from 
its nucleotide sequence. Additionally, in order to determine the 
copy number of the human cathepsin C gene, Southern blot 
analysis was performed. 
2. Materials and methods 
2.1. Materials 
Restriction and DNA modifying enzymes were purchased from 
Boehringer-Mannheim (Germany) or Pharmacia (Sweden). All other 
chemicals of analytical grade were from Sigma (USA) and Serva (Ger- 
many) unless otherwise stated. Oligonucleotides were synthesized on an 
Applied Biosystems 381A DNA synthesizer (USA) and purified by 
polyacrylamide g l electrophoresis. [0~-35S]dGTP and [c~-35S]dATP used 
for hybridization and nucleotide sequencing, and nylon membranes 
(Hybond-N) were obtained from Amersham (UK). The bacterial strain 
E. coli Y1090 hsdR, used as a host for bacteriophage 2gtl 1, was from 
Amersham, while E. coli DH5a was obtained from Gibco-BRL (USA). 
Plasmids pGEM-11Zf(-) and pUC19 were purchased from Promega 
(USA) and Pharmacia, respectively. 
2.2. cDNA library construction 
Total RNA was isolated from human ileum by the guanidinium 
thiocyanate/cesium trifluoroacetate m thod [12,13]. Poly(A) ÷ RNA was 
purified by affinity chromatography on oligo(dT)-cellulose [14]. cDNA 
was synthesized using a cDNA Synthesis System Plus of Amersham. 
After fractionation by gel chromatography, a size-enriched cDNA of 
more than 400 bp was used for the construction of a cDNA library in 
2gtll using a cloning kit from the same manufacturer. 
2.3. Preparation of a probe for screening 
In order to obtain the hybridization probe, total RNA was extracted 
from a rat kidney by the guanidinium thiocyanate/cesium trifluoroace- 
tate method [12,13], and poly(A) ÷ RNA was separated by affinity 
chromatography on oligo(dT)-cellulose [14]. The first strand of cDNA 
was performed with reverse transcriptase using an oligo(dT)t6 primer. 
The single-stranded DNA was amplified using a PCR kit (Perkin- 
Elmer Cetus) with two oligonucleotide primers 5'-CCGAATTCGAA- 
TGACTACAAGTGG-3' and 5'-CAGGGATCCGCCACGGACGT- 
TTCT-Y deduced from the nucleotide sequence of rat cathepsin C [5]. 
The amplified product of about 450 bp was cloned into pUC19, se- 
quenced and 35S-labeled using a Random Primed DNA Labeling kit 
(Boehringer Mannheim). 
2.4. Screening of cDNA library 
Recombinant plaques were transferred onto nylon membranes, fixed 
with ultraviolet light, and hybridized as described in [15] with 
35S-labeled probe (2 × 109 cpm/pg) at 42°C for 24 h. The replica filters 
were subsequently washed in 1 × SSC, 0.1% SDS at 25°C for 10 min, 
and 0.1 x SSC, 0.1% SDS at 50°C for 1 min, dried and exposed to 
Kodak X-Omat S film. Positive plaques were subjected to a second 
screening under the same conditions. 
2.5. Nuch'otide sequencing and sequence analys& 
Phage DNA containing cDNA for human cathepsin C was isolated 
from plate lysates using Wizard Lambda Preps DNA Purification Sys- 
tem (Promega). The cDNA was excised with XhoI, ligated into pGEM- 
11Zf(-) and sequenced by the dideoxy chain termination method (16) 
using a T7 sequencing kit (Pharmacia). The complete nucleotide se- 
quence of both strands was determined by use of internal primers 
constructed on the basis of the previously determined sequence. Nucle- 
All rights reserved. 
A. Pari,~ et al . /FEBS Letters 369 /1995) 326 330 327 
otide and protein sequences were analyzed on a computer by DNASIS 
(Pharmacia) and PC/GENE (IntelliGenetics, USA) programmes. 
2.6. Southern blot analysis 
20,ug of genomic DNA isolated from human spleen was digested with 
EcoRI, HindlII and PstI. The restriction fragments were separated by 
gel electrophoresis on a 0.6% agarose, blotted by capillary transfer 
(20xSSC, 20 h) onto Hybond-N nylon membrane and UV- 
crosslinked. A cDNA fragment of the first 510 bp, corresponding to the 
5'-end of the C I clone, was labeled by random priming with [~2P]dGTP 
(110 TBq/mmol, Amersham) using a Random Primed DNA Labeling 
Kit (Boehringer Mannheim). The Southern blot was hybridized at 42°C 
for 24 h in 6 x SSC, 5 x Denhardt's solution, 50% deionized formamide, 
0.1% SDS and 50 mg/ml of sonicated salmon sperm DNA. Washes were 
1 AAT TCT  TCA CCT CTT  TTC TCA GOT CCC TGC AGO ATG GGT GOT OGG CCC TCC TTG CTG CTC GOC GOC 66 
1 M@t G ly  A Ia  G Iy  Pro Set  Leu Leu Leu A la  A I&  ii 
67 CTC CTG CTG CTT  CTC TCC GGC GAC GGC GCC GTG CGC TOC GAC ACA CCT GCC AAC TGC ACC TAT  CTT  132 
12 Leu  Leu  Leu Leu  Leu S@r  G Iy  Asp  G ly  A la  Va l  Arg  Cys Asp  Thr  Pro A Ia  Ash  Cys Thr  Tyr  Leu 33 
133 GAC CTG CTG GGC ACC TGG GTC TTC CAG GTG GGC TCC AGO GGT TCC CAG CGO GAT GTC AAC TGC TCG 198 
34 Asp  Leu Leu  G Iy  Thr  T rp  Va l  Ph@ Gl0  V&I  G I¥  S@r ger  G I¥  S@r G ln  Arg  Asp Va l  Ash  cys Ser  55 
198 GTT  ATG GGA CCA CAA GAA AAA AAA GTA GTG GTG TAC CTT  CAG AAG CTG GAT ACA GCA TAT  GAT GAC 264 
56 Va l  1@t  G I¥  Pro G ln  G lu  Lys  Lys  Va l  Va l  Va l  Tyr  Leu G ln  Lys Leu Asp  Thr  A I&  Tyr  Asp  Asp  77 
265 CTT  GGC AAT TCT  GGC CAT TTC ACC ATC ATT  TAC AAC CAA GGC TTT  GAG ATT  GTG TTG AAT GAC TAC 330 
78 Leu  G ly  Ash  S@r G Iy  His  Ph@ ThE I f@ I f@ Tyr  ASh  G ln  G IF  Phe G lu  I f@ Va l  Leu  Ash  Asp  Tyr  99 
331 AAG TGG TTT  GCC TTT  TTT  AAG TAT  AAA GAA GAG GGC AGO AAG GTG ACC ACT TAC TGC AAC GAG ACA 396 
I00 Lys TEp Ph@ A la  Ph@ Ph@ Lys  Tyr  Lys O lu  G lu  G ly  S@r Lys  Va l  Thr  Thr  Tyr  Cys  Ash  G lu  Thr  121 
397 ATG ACT GGG TGG GTG CAT GAT GTO TTG GGC CGG AAC TGG GOT TGT TTC ACC GGA AAG AAG GTG GGA 462 
122 M@t  Thr  G I¥  T rp  Va l  His  Asp  Va l  Leu  G I¥  Arg  Ash  Trp  A la  Cys Phe Thr  G I¥  Lys Lys Va l  G Iy  143 
463 ACT GOC TCT GAG AAT GTG TAT  GTC AAC ACA GCA CAC CTT  AAG AAT TCT  CAG GAA AAG TAT  TCT  AAT 528 
144 Thr  A la  Set  G lu  Ash  Va l  Tyr  V&I  Ash  Thr  A I&  His  Leu Lys Ash  Set  G ln  G lu  Lys Tyr  Bet  Ash  165 
529 AGG CTC TAC AAG TAT  GAT CAC AAC TTT  GTG AAA GOT ATC AAT GOC ATT  CAG AAG TCT TGG ACT GOA 594 
166 Arg  Leu Tyr  Lys  Tyr  Asp  His  Ash  Phe Va l  Lys A la  I le ASh  A la  I le G ln  Lys Ser  T rp  Thr  A la  187 
595 ACT ACA TAC ATG GAA TAT  GAG ACT CTT  ACC CTG GGA GAT ATO ATT  AGG AGA AGT GGT GGC CAC AGT 660 
188 Thr  Thr  Tyr  M@t  G lu  Tyr  G lu  Thr  Leu  Thr  Leu G ly  Asp Met  I f@ Arg  Arg  S@r G I¥  G Iy  His  Set  208 
661 CGA AAA ATC CCA AGG CCC AAA CCT GCA CCA CTG ACT OCT GAA ATA CAG CAA AAG ATT  TTG CAT TTG 726 
210 Arg  Lys I f@ Pro  Ar~ Pro Lys  Pro A la  Pro Leu Thr  A la  G lu  I le G ln  G ln  Lys I i@ Leu His  Leu 231 
727 CCA ACA TCT  TGG GAC TGG AGA AAT GTT  CAT GGT ATC AAT TTT  GTC AGT CCT GTT  CGA AAC CAA GOA 792 
232 Pro Thr  S@r  Trp  Asp  Trp  Arg  Ash  V . I  H is  G ly  I i@ Asn  Ph@ Va l  Ser  Pro Va l  Arg  Ash  G ln  A la  253 
793 TCC TOT GGC AGO TGC TAC TCA TTT GCT TCT  ATG GGT ATO 
254 8er  CyS O l¥  Set  Cys Tyr  Ser  Phe A Ia  Ser  Met  G ly  Met  
1 
859 A~C I~.T  '~T  CAG ACC CCA ATC CTA AGO CCT CAG GAG G' I~ 
276 ASh Ash  S@r O ln  Thr  Pro I i@ Leu  Ser  Pro G ln  G lu  Val  
CTA GAA GCG AGA ATC CGT ATA CTA ACC 858 
Leu G lu  A la  Arg  I le Arg  I le Leu Thr  275 
GTG TCT TGT AGC CAG TAT  GCT CAA GGC 924 
Val  Ser  Cys Ser  G in  Tyr  A I&  G ln  G Iy  297 
925 TGT GAA GGC GGC TTC CCA TAC CTT  ATT  GCA GGA AAG TAC GCC CAA GAT TTT  GGG CTG GTG GAA GAA 990 
298 Cys G Iu  G ly  G I¥  Ph@ Pro TyE  Leu I le  A la  G ly  Lys Tyr  A Ia  G ln  Asp  Phe G ly  Leu V&I  G lu  U lu  319 
991 GOT TGO TTC CCC TAC ACA GGC ACT GAT TCT  CCA TGC AAA ATG AAG GAA GAC TGC TTT  CGT TAT  TAC 1056 
320 A la  Cys Ph@ Pro Tyr  Thr  G I¥  Thr  Asp  set  Pro Cys Lys M@t Lys G lu  Asp  Cys Ph@ Arg  Tyr  Tyr  341 
1057 TCC TCT  GAG TAC CAC TAT  GTA GGA GGT TTC TAT  GGA GGC TGC AAT GAA GCC CTG ATG AAG CTT  GAG 1122 
342 Set  Ser  G lu  Tyr  His  Tyr  Va l  O ly  G ly  Ph@ Tyr  G Iy  G ly  Cys As•  G lu  A Ia  Leu  Met  Lys Leu  G lu  363 
1123 TTG GTC CAT CAT GGG CCC ATG GCA GTT  GCT TTT  GAA GTA TAT  GAT GAC TTC CTC CAC TAC AAA AAG 1188 
364 Leu Va l  His  His  G ly  Pro M@t A la  Va l  A Ia  Ph@ Glu  Va l  Tyr  Asp  Asp  Phe Leu His  Tyr  Lys  Lys 385 
1188 GGG ATC TAC CAC CAC ACT GGT CTA AGA GAC CCT TTC AAC CCC TTT  GAG CTG ACT AAT CAT GCT GTT 1254 
386 GIy  I le  Tyr  H is  Him Thr  G I¥  Leu  Arg  Asp  Pro Phe Amn Pro Phe G lu  Leu Thr  Aan  His  A la  Va l  407 
A 
1255 CTG CTT  GTG GGC TAT  GGC ACT GAC TCA GCC TCT  GGG ATG GAT TAC TGG ATT  GTT  AAA AAC AGC TGG 1320 
408 Leu LeU Va l  G Iy  Tyr  G ly  Thr  Asp  Ser  A la  S@r GIy  Xet  Asp  Tyr  Trp  I le V&I  Lys Ash  Set  Trp  429 
1321 GGC ACC GGC TGG GGT GAG AAT GGC TAC TTC CGG ATC CGC AGA GGA ACT GAT GAG TGT GCA ATT  GAG 1386 
430 GZy ThE  G ly  T rp  G Iy  O lu  Asn  GZy Tyr  Phe Arg  I I@ Arg  Arg  G Iy  Thr  Asp  Glu Cys A Ia  I le Glu 451 
1387 AGC ATA GCA GTG GCA GCC ACA CCA ATT  CCT AAA TTG TAG GGT ATG CCT TCC AGT ATT  TCA TAA TGA 1452 
452 Ser  I le  A la  V&I  A Ia  A1a  Thr  Pro I le Pro  Lys Leu *** 464 
1453 TCT  GCA TCA GTT  GTA AAG GGG AAT TGG TAT  ATT  CAC 
1519 AGC TTA CAA ATA GAT TTC CAT GAA GAT ATT  TGT CTT  
1585 ACC TTT  CAA TCG GCC ACT GGC CAT TTT  TTT  CTA AGT 
1651 GGT CAO CTA TGA AGT AAT AGA GTT  TGC TTA ATC ATT  
1717 TCA ATQ TGA AAA CAT AGA CTT  ATT  TTT  AAA TTG TAC 
1783 CAA AAC TTT  TAA AAT AGA TGC TCA TAT  TTT  TAA AAT 
1849 AAA AAA AAA 
AGA CTG TAG ACT TTC AGC AGC AAT CTC AGA 1518 
CAG AAT TAA AAC TGC CCT TAA TTT  TAA TAT  1584 
ATT  CAA TTA AGT GGG AAT TTT  CTO GAA GAT 1650 
TGT AAT TCA AAC ATG CTA TAT  TTT  TTA AAA 1716 
CAA TCA CAA GAA AAT AAT GGC AAT AAT TAT  1782 
AAA GTT  TTA AAA ATA ACT GCA AAA AAA AAA 1848 
1857 
Fig. 1. The nuclcotide and deduced amino acid sequences of preprocathepsin C. Polyadenilation signal is underlined, The protein sequence r gion 
is numbered starting from the putative initiation methionine and ending by the termination codon. Two amino acid residues (Cys ~ss and His 4~.5) 
important for the catalytical activity are designated with arrowheads. These data have been submitted to the GenBank and have been assigned 
accession  umber X87212. 
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performed at 42°C, 55°C and 65°C in 2 x SSC, 0.1% SDS; 1 x SSC, 
0.1% SDS and 0.1 x SSC, 0.1% SDS. The washed membrane was ex- 
posed to X-ray film. 
3. Results and discussion 
The aim of this study was to isolate clones coding for human 
cathepsin C and to determine its primary structure. In order to 
obtain a probe for screening, a DNA isolated from human 
ileum cDNA library was first used as a template. However, 
PCR analysis with the primers corresponding to the rat cathep- 
sin cDNA [5] did not give any positive bands, therefore we 
decided to isolate total RNA from rat kidney. After poly(A) + 
RNA enrichment, he sample was subjected to reverse tran- 
scription and subsequent PCR amplification. The nucleotide 
sequence of the PCR product was confirmed and the probe was 
radioactively-labeled. Screening of about 2 x 105 independent 
clones from a human ileum cDNA library with the rat cDNA 
probe resulted in the isolation of four independent clones. The 
C1 cDNA clone with an approximative l ngth of 2 kb was 
finally isolated and, after subcloning, completely sequenced. 
The nucleotide sequence and the primary structure of the C 1 
clone deduced from its cDNA sequence are shown in Fig. 1. 
The 1857 bp cDNA contains an open reading frame of 1389 
nucleotides, corresponding to an encoded preproprotein of 463 
amino acid residues with a calculated molecular mass of 51848 
Da. The initiation codon was assigned to the first in-frame 
ATG at position 34 which almost perfectly matches to the 
consensus Kozak sequence [17]. The coding sequence nds with 
a TAG stop codon at position 1323-1325. The 3'-untranslated 
region consisting of 413 nucleotides is followed by a short 
poly(A) tail. A putative polyadenylation signal (AATAAA), 
which is common to eukaryotic mRNAs, is located 23 nucleo- 
tides upstream of the poly(A) addition site. The first 24 amino 
acid residues of the protein show a typical hydrophobic charac- 
ter, similar to other eukaryotic signal sequences. 
The N-terminal amino acid sequences of three polypeptide 
chains obtained by partial protein sequencing of cathepsin C
isolated from human spleen [18] were confirmed in the deduced 
amino acid sequence of the C l clone. The deduced protein 
sequences D25TPANCTYLD 34 and L231pTSWDWRN 239 corre- 
spond, by analogy with other cysteine proteinases, to the start 
of the proregion and of the mature region of cathepsin C, 
respectively. The third deduced sequence D395pFNPFELTN 4°4 
probably represents he N-terminal end of the light chain of the 
mature protein. It was previously shown that an approximately 
17 kDa polypeptide, with N-terminal amino acid sequence cor- 
responding to the proregion of cathepsin C, was present in 
purified mature nzyme, indicating that a substantial part of the 
proregion still remains bound in the mature cathepsin C [10,18]. 
McGuire and co-workers [11] reported on the purification 
and characterization f dipeptidyl aminopeptidase I (cathepsin 
C) from human spleen. After isolation of cathepsin C, the 
purified protein was partially digested with trypsin and resulted 
fragments were analyzed by Edman degradation. Altogether 
141 sequenced amino acid residues, compartmented into nine 
fragments, represent approximately 45% of mature cathepsin 
C. Comparison of the deduced amino acid sequence of CI clone 
with the sequence of all nine fragments reveals 6 different 
amino acid residues. Rather unexpectedly, two cysteine resi- 
dues (Cys  321 and Cys 355) which are found in the deduced se- 
kb 
23.1  - -  
9 .4  
6 .6  m 
4 .4  
2.3 m 
2.0 
1 2 3 
Fig. 2. Southern blot analysis of human genomic DNA using a 510 bp 
fragment of human preprocathepsin cDNA. Lanes 1 3 contain 
genomic DNA digested with EeoRI, PstI and HindIII, respectively. 
quence of C1 clone and are preserved in the sequence of rat 
cathepsin C [5] are missing in the analyzed fragments [11]. The 
differences in the amino acid composition might be due to the 
presence of two related genes in human genome. Therefore, in 
order to determine the copy number of the human cathepsin 
C gene, a Southern blot ofgenomic DNA digested with EcoRI, 
Pstl and HindlII, respectively, was probed using a fragment 
corresponding to the first 510 bp of the C1 clone (Fig. 2). By 
analogy to the structures of the mouse cathepsin B gene [19], 
human cathepsin S gene [20] and human cathepsin L gene [21], 
at least one intron may be present within a selected region 
covering by the probe. Additionally, an internal PstI restriction 
site is located within the sequence of the probe. Digestion of 
genomic DNA with HindlII gave two strong bands whereas 
EcoRI and PstI digestion resulted in the presence of three 
bands. These results suggest hat restriction enzymes may cut 
within the presumed intron region or that two copies of cathep- 
sin C are present in human genome. The gene organization of 
other cathepsins [19-21] suggests that all three restriction sites 
are located in the intron domain. 
Search for protein modification sites in the predicted prepro- 
cathepsin C sequence with the PC/GENE programme revealed 
that there are four potential N-glycosylation sites at residues 
29, 53, 119 and 276. This is in agreement with the results 
reported for rat liver cathepsin C [10] where it was shown that 
the monomeric form of cathepsin C is composed of two 
glycoprotein subunits with at least two glycosylation sites. Ad- 
ditionally, two potential tyrosine sulfatation sites were found 
at residues 75 and 340, four potential protein kinase C phos- 
phorylation sites at residues 48, 138, 164 and 209, and four 
potential myristylation sites at residues 2, 44, 111, and 256. 
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1 . . . . . . . . . . . .  i0  . . . . . . . . . .  20  . . . . . . . .  30  . . . . . . . .  40  . . . . . . . . . .  50  . . . . . . . . . . .  
pap I PEYVD . . . .  WRQ-KG- -AVTPVKNQGSCGSCWAFSAVIPT IEGI IK IRTGNLNE- -YSEQELLDCD-R-R  
catB  LPASFDAREQWPQ-CP- -T IKE IRDQGSCGSCWAFGAVEAISDRIC IHTNAHVSVEVSAEDLLTCC-GSM 
cat H YPPSVD . . . .  WRK-KG-NFVSPVKNQGACGSCWTFSTTGALESAIA IATGKMLS- -LAEQQLVDCA-QDF 
carL APRSVD . . . .  WRE-KG- -YVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRL IS - -LSEQNLVDCS-GPQ 
catS LPDSVD . . . .  WRE-KG- -CVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVT- -LSAQNLVDCSTEKY 
cat O LPLRFD . . . .  WRD-KQ- -VVTQVRNQQMCGGCWAFSVVGAVESAYAIK -GKPLED-LSVQQVIDCS- - -Y  
cat K APDSVD . . . .  YRK-KG- -YVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLN- -LSPQNLVDCVSE- -  
ca tC  LPTSWD . . . .  WRNVHGINFVSPVRNQASCGSCYSFASMGMLEARIR ILTNNSQTPILSPQEVVSCS-Q Y 
* * * **  * * * 
60  . . . . . . . .  70  . . . . . . . . . .  80  . . . . . . . . . . . . . . .  90  . . . . . . . . . . . . . . . .  i00  . . . . . . . . . .  
pap -SYGCNGGYPWS-ALQLVAQY-GIHYRNTY . . . . . . .  PYEGVQ . . . . . . . .  RYCRSREKG . . . . . . . . .  
ca tB  CGDGCNGGYPAE-AWNFWTR-KGLVSGGLYESHVGCRPYS IPPCEHHVNGSRPPCTGEGDTPKCSKICEP  
cat H NNYGCQGGLPSQ-AFEY ILYNKGIMGEDTY . . . . . . .  PYQGKD . . . . . . . . .  GYCKFQPGK . . . . . . . . .  
carL  GNEGCNGGLMDY-AFQYVQDNGGLDSEESY . . . . . . .  PYEATE . . . . . . .  ESCKYNPKY . . . . . . . . . .  
cats  GNKGCNGGFMTT-AFQYI IDNKGIDSDASY-  - -PYKAMD . . . . . . . .  QKCQYDSKY . . . . . . . . .  
cat O NNYGCNGGSTLN-ALNWLNKMQVKLVKDSEY . . . . . .  PFKAQN GLCHYFSGS . . . . . . . . . .  
cat K -NDGCGGGYMTN-AFQYVQKNRGIDSEDAY . . . . . . .  PYVGQE . . . . . . . . .  ESCMYNPTG - -  
ca tC  -AQGCEGGFPYL IAGKY-AQDFGLV EEACF - -PYTGTD . . . . . . . .  SPCKMKEDC- -  
. . . . . . . . . . .  i i 0  . . . . . . . .  120  . . . . . . . .  130  . . . . . . .  140  . . . . . . .  150  . . . . . . . . . . . . . .  
pap PYAAKTD . . . . .  GVRQVQPYN-  EGALLYS IAN-QPVSVVLEAAGKDFQLYRGG IFVGP-  CG-  - -NKV-  - 
cat B GYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFS-VYSDFLLYKSGVYQH-  -VT-  GEMMG-  - - 
cat H A IGFVK . . . . .  DVANIT  IY -  DEEAMVEAVALYNPVSFAFE-  VTQDFMMYRTG IYSSTSCHKTPDKV 
catL  SVANDT . . . . . .  GFVDI  PKQ-  - EKALMKAVATVGP I SVAIDAGHESFLFYKEG IYFE  PDCSS-  EDM . . . .  
cat S RAATCS . . . . . .  KYTELPYG-  REDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYE PSCTQ-  -NV . . . .  
cat O HSGFS IK  . . . . .  GYSAYDFSDQEDEMAKALLTFGPLVVIVDAV-  - SWQDYLGG I IQHH-  CSSGEA . . . .  
cat K KAAKCR . . . . . .  GYRE I PEGN-  EKALKRAVARVGPVSVA I DASLTSFQFYSKGVYYDESCNS-  DNL . . . .  
cat C FRYYSS-  - -  EYHYVGGFYGGCNEALMKLELVHHGPMAVAFE-VYDDFLHYKKG IYHHTGLRDPFNPFELT  
160 . . . . . . . . . . . . .  170  . . . . . . .  180  . . . . . . .  190  . . . . . . .  200  . . . . . . . . .  210  . . . . . . . .  
pap DHAVAAVGYGPN-  - -  Y IL IKNSWGTGWGENGYIR IKRGTGNSYGVCGLYT- -SSFYPVKN-  
cat  B GHAIR ILGWGVENG- -TPYWLVANSWNTDWGDNGFFK ILRGQDH . . . .  CGIESEVVAGIPRTDQYWEKI  
~atH NHAVLAVGYGEKNG- - IPYWIVKNSWGPQWGMNGYFL IERGK-NM- - -CGLAACAS- -YP IPLV  . . . . .  
ca t  L DHGVLVVGYGFESTNNK-YWLVKNSWGEEWGMGGYVKMAKDRRNH- - -CGIASAAS- -YPTV . . . .  
ca tS  NHGVLVVGYGDLNG- -KEYWLVKNSWGHNFGEEGYIRMARNKGNH-  -CGIASFPS- -YPE I  . . . . . . .  
cat  O NHAVL ITG-FDKTGS-TPYWIVRNSWGSSWGVDGYAHVKMGS-NV- -  CGIADSVSS- IFV  . . . . . .  
cat K NHAVLAVGYGIQKGN- -KHWI IKNSWGENWGNKGYILMARNKNNA- -  CGIANLASF- -PKM . . . . . . .  
cat  C NHAVLLVGYGTDSASGMDYWIVKNSWGTGWGENGYFRIRRGTDE . . . .  CA IES IAVAATP IPKL  . . . .  
* ***  * * * 
Fig. 3. Comparison of the deduced amino acid sequence ofthe mature region of human cathepsin C with the papain [24] and human cathepsins B 
[25], H [26], L [27], S [28], O [29] and K [30]. Numbering isaccording to papain. Gaps introduced to optimize the alignment are denoted by a dash. 
An asterisk (*) indicates the conserved amino acid residue in all compared sequences. 
Comparison of the deduced amino acid sequences of human 
preprocathepsin C with its rat counterpart [5] reveals that 
87.5% of amino acid residues are identical (data not shown). 
Fig. 3 shows a multiple alignment of the deduced amino acid 
sequence of the mature region of human cathepsin C with 
cysteine proteinases of the papain superfamily. According to 
the alignment, he deduced amino acid sequence of human 
cathepsin C shows 33%, 32%, 37%, 33.3%, 32%, 28.5% and 33% 
identity with papain and human cathepsins B, H, L, S, O and 
K, respectively. The amino acid sequence of human cathepsin 
H shares the highest degree of identity with human cathepsin 
C. Both N- and C-terminal parts of these cysteine proteinases 
are conserved more than the central regions. The amino acid 
residues Cys 25, His 159 (papain umbering), which are proposed 
to be important for the catalytic activity, as well as Gln 19, Asn ~75 
and Trp 17v [2,22], are conserved in human cathepsin C and all 
the sequences compared. As in rat cathepsin C, a tyrosine 
residue (Tyr 26) next to the cysteine in the active site in the 
human cathepsin C sequence is substituted for tryptophan res- 
idue, which is otherwise conserved among other cysteine pro- 
teinases. This substitution might affect substrate specificity. 
Secondary structures of some cysteine proteinases were pre- 
dicted by hydropathy analysis [23] (Fig. 4). Although there is 
a relatively small degree of sequence identity within the amino 
acid sequences of cathepsins H, L, S and C, there is a striking 
similarity in the hydrophobicity patterns which reflects struc- 
tural and functional similarities in these proteins. 
The availability of a cDNA for human preprocathepsin C 
will enable further studies on tissue-distribution and expression 
of cathepsin C in normal and pathological conditions which 
will, at least partially, clarify the role of cathepsin C in different 
physiological stages and disorders. 
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